Keywords
Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Piribedil (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Piribedil (pharmacology) < Piribedil (therapeutic use) < Pituitary Neoplasms (secretion)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000268 (2002) Anne-Marie Bonnet [France][Alpha-2 adrenergic receptors and Parkinson's disease].
000406 (2003) N V Fedorova[Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].
000505 (2005) Nicolas Simon [France] ; Joëlle Micallef ; Jean-Charles Reynier ; Monique Lesourd ; Tatiana Witjas ; André Alicherif ; Jean-Philippe Azulay ; Olivier BlinEnd-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: a pharmacokinetic/pharmacodynamic, randomized, double-blind study.
000573 (1992) P. Rondot [France] ; M. ZieglerActivity and acceptability of piribedil in Parkinson's disease: a multicentre study.
000637 (2006) Nathalie Turle-Lorenzo [France] ; Béatrice Maurin ; Carole Puma ; Claire Chezaubernard ; Philippe Morain ; Christelle Baunez ; André Nieoullon ; Marianne AmalricThe dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.
000650 (2006) Olivier Rascol [France] ; Bruno Dubois ; Alexandre Castro Caldas ; Stephen Senn ; Susanna Del Signore ; Andrew LeesEarly piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study.
000B75 (2010) Mark J. Millan [France]From the cell to the clinic: a comparative review of the partial D₂/D₃receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease.
001113 (2013) Stéphane Thobois [France] ; Eugénie Lhommée ; Hélène Klinger ; Claire Ardouin ; Emmanuelle Schmitt ; Amélie Bichon ; Andrea Kistner ; Anna Castrioto ; Jing Xie ; Valerie Fraix ; Pierre Pelissier ; Stephan Chabardes ; Patrick Mertens ; Jean-Louis Quesada ; Jean-Luc Bosson ; Pierre Pollak ; Emmanuel Broussolle ; Paul KrackParkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
001C72 (1993) J L Montastruc [France] ; O. Rascol ; J M SenardCurrent status of dopamine agonists in Parkinson's disease management.
001E72 (1997) O. Moreaud ; N. Fournet ; J L Roulin ; B. Naegele ; J. PellatThe phonological loop in medicated patients with Parkinson's disease: presence of phonological similarity and word length effects.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Piribedil (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Piribedil (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Piribedil (therapeutic use)
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024